The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
pH‐dependent antitumor activity of proton pump inhibitors against human melanoma is mediated by inhibition of tumor acidity
Abstract
Metastatic melanoma is associated with poor prognosis and still limited therapeutic options. An innovative treatment approach for this disease is represented by targeting acidosis, a feature characterizing tumor microenvironment and playing an important role in cancer malignancy. Proton pump inhibitors (PPI), such as esomeprazole (ESOM) are prodrugs functionally activated by acidic environment, fostering pH neutralization by inhibiting proton extrusion. We used human melanoma cell lines and xeno‐transplated SCID mice to provide preclinical evidence of ESOM antineoplastic activity. Human melanoma cell lines, characterized by different mutation and signaling profiles, were treated with ESOM in different pH conditions and evaluated for proliferation, viability and cell death. SCID mice engrafted with human melanoma were used to study ESOM administration effects on tumor growth and tumor pH by magnetic resonance spectroscopy (MRS). ESOM inhibited proliferation of melanoma cells in vitro and induced a cytotoxicity strongly boosted by low pH culture conditions. ESOM‐induced tumor cell death occurred via rapid intracellular acidification and activation of several caspases. Inhibition of caspases activity by pan‐caspase inhibitor z‐vad‐fmk completely abrogated the ESOM‐induced cell death. ESOM administration (2.5 mg kg−1) to SCID mice engrafted with human melanoma reduced tumor growth, consistent with decrease of proliferating cells and clear reduction of pH gradients in tumor tissue. Moreover, systemic ESOM administration dramatically increased survival of human melanoma‐bearing animals, in absence of any relevant toxicity. These data show preclinical evidence supporting the use of PPI as novel therapeutic strategy for melanoma, providing the proof of concept that PPI target human melanoma modifying tumor pH gradients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Hirpara, J. L., Clement, M., & Pervaiz, S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m004687200 · Cited by 145
Retracted(1989) · PubMed · Cited by 3,343
Cancer cell metabolism: warburg and beyond
Hsu, P. P., & Sabatini, D. M. (2008) · Cell · doi:10.1016/j.cell.2008.08.021 · Cited by 2,452 · cited 3×
“Acidity of human solid tumors is involved in tumor progression and malignancy, mostly by inducing a selection of cells adapted through an altered metabolism to survive in hostile conditions.(2) Recent in vivo studies on animal models and also in patients with oral cancer have shown an acidic extracellular pH (pHe) and…”
BackgroundInfluentialTumor cell metabolism: cancer's Achilles' heel
Kroemer, G., & Pouyssegur, J. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.05.005 · Cited by 2,337
Drug Resistance and the Solid Tumor Microenvironment
Tredan, O., Galmarini, C. M., Patel, K., & Tannock, I. F. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djm135 · Cited by 2,116 · cited 1×
“This may have important consequences not only on the capacity of malignant cells to proliferate and survive in acidic conditions but also on distribution and penetration of chemotherapeutics in tumor microenvironment and tumor cells.(3,5,48) Consistent with the derangement of tumor pH gradients, ESOM clearly inhibited…”
Background(1989) · PubMed · Cited by 1,639
Vacuolar ATPases: rotary proton pumps in physiology and pathophysiology
Forgac, M. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2272 · Cited by 1,619
The vacuolar (H+)-ATPases — nature's most versatile proton pumps
Nishi, T., & Forgac, M. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm729 · Cited by 1,197
Morton, D., & Griffiths, P. (1985) · Veterinary Record · doi:10.1136/vr.116.16.431 · Cited by 1,037
Recent progress in tumor pH targeting nanotechnology
Lee, E. S., Gao, Z., & Bae, Y. H. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.05.003 · Cited by 866
Magnetic resonance imaging of pH in vivo using hyperpolarized 13C-labelled bicarbonate
Gallagher, F. A., Kettunen, M. I., Day, S. E., Hu, D.-E., Ardenkjær-Larsen, J. H., Zandt, R. I. ‘., Jensen, P. R., Karlsson, M., Golman, K., Lerche, M. H., et al. (2008) · Nature · doi:10.1038/nature07017 · Cited by 849
Matsuyama, S., Llopis, J., Deveraux, Q. L., Tsien, R. Y., & Reed, J. C. (2000) · Nature Cell Biology · doi:10.1038/35014006 · Cited by 744
A microenvironmental model of carcinogenesis
Gatenby, R. A., & Gillies, R. J. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2255 · Cited by 721
Korn, E. L., Liu, P.-Y., Lee, S. J., Chapman, J.-A. W., Niedzwiecki, D., Suman, V. J., Moon, J., Sondak, V. K., Atkins, M. B., Eisenhauer, E. A., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.12.7837 · Cited by 705
Rofstad, E. K., Mathiesen, B., Kindem, K., & Galappathi, K. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0983 · Cited by 668
Bicarbonate Increases Tumor pH and Inhibits Spontaneous Metastases
Robey, I. F., Baggett, B. K., Kirkpatrick, N. D., Roe, D. J., Dosescu, J., Sloane, B. F., Hashim, A. I., Morse, D. L., Raghunand, N., Gatenby, R. A., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-07-5575 · Cited by 661
Studies of human tumors by MRS: A review
Negendank, W. (1992) · NMR in Biomedicine · doi:10.1002/nbm.1940050518 · Cited by 660
Griffiths, Jr. (1991) · British Journal of Cancer · doi:10.1038/bjc.1991.326 · Cited by 594
Acidic pH enhances the invasive behavior of human melanoma cells
Mart�nez-Zaguil�n, R., Seftor, E. A., Seftor, R. E. B., Chu, Y.-W., Gillies, R. J., & Hendrix, M. J. C. (1996) · Clinical & Experimental Metastasis · doi:10.1007/bf00121214 · Cited by 507
Effect of Proton Pump Inhibitor Pretreatment on Resistance of Solid Tumors to Cytotoxic Drugs
Luciani, F., Spada, M., De Milito, A., Molinari, A., Rivoltini, L., Montinaro, A., Marra, M., Lugini, L., Logozzi, M., Lozupone, F., et al. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh305 · Cited by 435
Self-citationReshkin, S. J., Bellizzi, A., Caldeira, S., Albarani, V., Malanchi, I., Poignee, M., Alunni‐Fabbroni, M., Casavola, V., & Tommasino, M. (2000) · The FASEB Journal · doi:10.1096/fj.00-0029com · Cited by 366
Tumor pH controls the in vivo efficacy of weak acid and base chemotherapeutics
Gerweck, L. E., Vijayappa, S., & Kozin, S. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0024 · Cited by 362
Sennoune, S. R., Bakunts, K., Martínez, G. M., Chua-Tuan, J. L., Kebir, Y., Attaya, M. N., & Martínez-Zaguilán, R. (2004) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00407.2003 · Cited by 333
Enhancement of chemotherapy by manipulation of tumour pH
Raghunand, N., He, X., Sluis, R. V., Mahoney, B., Baggett, B., Taylor, C. W., Paine-Murrieta, G., Roe, D., Bhujwalla, Z. M., & Gillies, R. J. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690455 · Cited by 316
Proton pump inhibitors: an update of their clinical use and pharmacokinetics
Shi, S., & Klotz, U. (2008) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-008-0538-y · Cited by 314
De Milito, A., Iessi, E., Logozzi, M., Lozupone, F., Spada, M., Marino, M. L., Federici, C., Perdicchio, M., Matarrese, P., Lugini, L., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4095 · Cited by 301
Self-citationVacuolar-type H(+)-ATPases are functionally expressed in plasma membranes of human tumor cells
Martinez-Zaguilan, R., Lynch, R. M., Martinez, G. M., & Gillies, R. J. (1993) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1993.265.4.c1015 · Cited by 291
Cannibalism of Live Lymphocytes by Human Metastatic but Not Primary Melanoma Cells
Lugini, L., Matarrese, P., Tinari, A., Lozupone, F., Federici, C., Iessi, E., Gentile, M., Luciani, F., Parmiani, G., Rivoltini, L., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3204 · Cited by 290
Self-citationTumor Acidity, Chemoresistance and Proton Pump Inhibitors
De Milito, A., & Fais, S. (2005) · Future Oncology · doi:10.2217/14796694.1.6.779 · Cited by 265
Self-citationTargeting Vacuolar H+-ATPases as a New Strategy against Cancer
Fais, S., De Milito, A., You, H., & Qin, W. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1805 · Cited by 264
Self-citationClastogenicity of low pH to various cultured mammalian cells
Morita, T., Nagaki, T., Fukuda, I., & Okumura, K. (1992) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/0027-5107(92)90235-t · Cited by 210
BRAF alterations are associated with complex mutational profiles in malignant melanoma
Daniotti, M., Oggionni, M., Ranzani, T., Vallacchi, V., Campi, V., Di Stasi, D., Torre, G. D., Perrone, F., Luoni, C., Suardi, S., et al. (2004) · Oncogene · doi:10.1038/sj.onc.1207780 · Cited by 210
Self-citationHinton, A., Sennoune, S. R., Bond, S., Fang, M., Reuveni, M., Sahagian, G. G., Jay, D., Martinez-Zaguilan, R., & Forgac, M. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m901201200 · Cited by 206
Williams, A. C., Collard, T. J., & Paraskeva, C. (1999) · Oncogene · doi:10.1038/sj.onc.1202660 · Cited by 196
Rich, I. N., Worthington-White, D., Garden, O. A., & Musk, P. (2000) · Blood · doi:10.1182/blood.v95.4.1427.004k48_1427_1434 · Cited by 188
Mattsson, J. P., Väänänen, K., Wallmark, B., & Lorentzon, P. (1991) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(91)90238-4 · Cited by 167
Lu, X., Qin, W., Li, J., Tan, N., Pan, D., Zhang, H., Xie, L., Yao, G., Shu, H., Yao, M., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3822 · Cited by 160
The role of acidity in solid tumour growth and invasion
B, K. S. A., Gavaghan, D. J., Gatenby, R. A., & Maini, P. K. (2005) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2005.02.001 · Cited by 157
Proton pump inhibitors: actions and reactions
Mullin, J. M., Gabello, M., Murray, L. J., Farrell, C., Bellows, J., Wolov, K., Kearney, K. R., Rudolph, D. S., & Thornton, J. J. (2009) · Drug Discovery Today · doi:10.1016/j.drudis.2009.03.014 · Cited by 131
Selective Induction of Apoptosis with Proton Pump Inhibitor in Gastric Cancer Cells
Yeo, M., Kim, D.-K., Kim, Y.-B., Oh, T. Y., Lee, J.-E., Cho, S. W., Kim, H. C., & Hahm, K.-B. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1065 · Cited by 120
Liu, D., Martino, G., Thangaraju, M., Sharma, M., Halwani, F., Shen, S., Patel, Y., & Srikant, C. B. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.13.9244 · Cited by 118
Raghunand, N., Mahoney, B. P., van Sluis, R., Baggett, B. K., & Gillies, R. J. (2001) · Neoplasia · doi:10.1038/sj.neo.7900151 · Cited by 114
Meisenholder, G. W., Martin, S. J., Green, D. R., Nordberg, J., BABIOR, B. M., & Gottlieb, R. A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.27.16260 · Cited by 105
Makovitzki, A., Fink, A., & Shai, Y. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3021 · Cited by 104
Schallreuter, K. U., Krüger, C., Würfel, B. A., Panske, A., & Wood, J. M. (2008) · International Journal of Dermatology · doi:10.1111/j.1365-4632.2008.03660.x · Cited by 102
Lozupone, F., Pende, D., BURGIO, V. L., Castelli, C., Spada, M., Venditti, M., Luciani, F., Lugini, L., Federici, C., Ramoni, C., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-1501 · Cited by 90
Self-citationBafilomycin A1 induces apoptosis in the human pancreatic cancer cell line Capan-1
Ohta, T., Arakawa, H., Futagami, F., Fushida, S., Kitagawa, H., Kayahara, M., Nagakawa, T., Miwa, K., Kurashima, K., Numata, M., et al. (1998) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199807)185:3<324::aid-path72>3.0.co;2-9 · Cited by 82
Specific Inhibitors of Vacuolar Type H+-ATPases Induce Apoptotic Cell Death
Nishihara, T., Akifusa, S., Koseki, T., Kato, S., Muro, M., & Hanada, N. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.1964 · Cited by 81
Provent, P., Benito, M., Hiba, B., Farion, R., López‐Larrubia, P., Ballesteros, P., Rémy, C., Segebarth, C. M., Cerdán, S., Coles, J. A., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3459 · Cited by 79
Vacuolar H+-ATPase: functional mechanisms and potential as a target for cancer chemotherapy
Torigoe, T., Izumi, H., Ise, T., Murakami, T., Uramoto, H., Ishiguchi, H., Yoshida, Y., Tanabe, M., Nomoto, M., & Kohno, K. (2002) · Anti-Cancer Drugs · doi:10.1097/00001813-200203000-00005 · Cited by 64
Raghunand, N., & Gillies, R. J. (2001) · Novartis Foundation symposium · doi:10.1002/0470868716.ch14 · Cited by 47
Moriyama, Y., Patel, V., Ueda, I., & Futai, M. (1993) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1993.2306 · Cited by 39
A role for intracellular pH in membrane IgM-mediated cell death of human B lymphomas
Marcheş, R., Vitetta, E. S., & Uhr, J. W. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.061028998 · Cited by 39
MicroArray Data Simulator For Improved Selection of Differentially Expressed Genes
Singhal, S. K., Kyvernitis, C. G., Johnson, S. W., et al. (2003) · Cancer Biology & Therapy · doi:10.4161/cbt.2.4.431 · Cited by 37
Coss, R. A., Storck, C., Daskalakis, C., Berd, D., & Wahl, M. (2003) · PubMed · Cited by 37
Mitochondria are not required for death receptor-mediated cytosolic acidification during apoptosis
Waibel, M., Kramer, S., Lauber, K., Lupescu, A., Manns, J., Schulze‐Osthoff, K., Lang, F. J. W., & Wesselborg, S. (2006) · APOPTOSIS · doi:10.1007/s10495-006-0006-z · Cited by 16
Cited by
Interfering with pH regulation in tumours as a therapeutic strategy
Neri, D., & Supuran, C. T. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3554 · Cited by 1,547
Acidic extracellular microenvironment and cancer
Kato, Y., Ozawa, S., Miyamoto, C., Maehata, Y., Suzuki, A., Maeda, T., & Baba, Y. (2013) · Cancer Cell International · doi:10.1186/1475-2867-13-89 · Cited by 1,300
Calcinotto, A., Filipazzi, P., Grioni, M., Iero, M., De Milito, A., Ricupito, A., Cova, A., Canese, R., Jachetti, E., Rossetti, M., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-1272 · Cited by 640
Self-citationDisrupting proton dynamics and energy metabolism for cancer therapy
Parks, S. K., Chiche, J., & Pouysségur, J. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3579 · Cited by 607
Cancer acidity: An ultimate frontier of tumor immune escape and a novel target of immunomodulation
Huber, V., Camisaschi, C., Berzi, A., Ferro, S., Lugini, L., Triulzi, T., Tuccitto, A., Tagliabue, E., Castelli, C., & Rivoltini, L. (2017) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.03.001 · Cited by 595
Self-citation
Metadata
- Authors
- De Milito, A., Canese, R., Marino, M. L., Borghi, M., Iero, M., Villa, A., Venturi, G., Lozupone, F., Iessi, E., Logozzi, M., Mina, P. D., Santinami, M., Rodolfo, M., Podo, F., Rivoltini, L., & Fais, S.
- Venue
- International Journal of Cancer
- Publisher
- Wiley
- Published
- 2010-04-21
- Volume
- 127
- Issue
- 1
- Pages
- 207-219
- ISSN
- 0020-7136 (ISSN-L)
- 1097-0215
- OpenAlex
- W2029272680
- Cited by
- 274
- References
- 56
- FWCI
- 2.91
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.